1Robert M, Gagnon C. Purification and characterization of the activeprecursor of ahuman sperm motility inhibitor secreted by the seminal vesicles:identity withsemenogelin[J]. Biol Reprod, 1996, 55(4): 813～821.
2Peter A, Lilja H, Lundwall A et al. Semenogelin I and semenogelin Ⅱ,the majorgel-forming protein in human semen, are substrates for transglutaminase[J]. Eur J Biochem,1998, 252(2): 216～221.
3Bjartell A, Malm J, Moller C et al. Distribution and tissue expressionofsemenogelin Ⅰ and Ⅱ in man as demonstrated by in situ hybridizationandimmunocytochemistry [J]. J Androl, 1996, 17(1): 17～26.
4Robert M, Gagnon C. Sperm motility inhibitor from human seminal plasma:associationwith semen coagulum [J]. Hum Reprod, 1995, 10(8): 2192～2197.
5Seregni E, Botti C, Ballabio G et al. Biochemical characteristics andrecentbiological knowledge on prostate-specific antigen [J]. Tumori, 1996, 82(1):72～77.
6Robert M, Gibbs BE, Jacobson E et al. Characterization ofprostate-specific antigenproteolytic activity on its major physiological substrate, the sperm motility inhibitorprecursor/semenogelin I [J]. Biochemistry, 1997,36(13):3811～3819.
7Lilja H, Abrahamsson PA, Lundwall A. Semenogelin, the predominantprotein in humansemen [J]. J Biol Chem, 1989, 264(3):1894～1900.
8van Wersch JW, De Vries-Hanje JC, Ubachs JM. Coagulation and fibrinolysismarkersin seminal plasma of patients under evaluation for involuntary childlessness[J]. Eur JChin Chem Clin Biochem, 1992, 30(8): 467～471.
9Park JY, Yoshimura Y, Nozawa S et al. Fibrinogen-like substance andthrombin-likeenzyme in seminal plasma: coagulation system of human semen [J].Arch Androl, 1997, 38(1):29～36.
10Matsuda Y, Oshio S, Yazaki T et al. The effect of some proteinaseinhibitors onliquefaction of human semen [J]. Hum Reprod, 1994, 9(4): 664～668.
